<qa>  What is the goal of the Phase II randomized study?This Phase II randomized study is to determine whether once-daily simultaneous modulated accelerated thoracic radiotherapy RT resulted in better survival than twice-daily RT for patients with limited-stage small-cell lung cancer LD-SCLC. 